2-Cyclohexylisonicotinamide

Catalog No.: 
ACPXBT690
CAS No.: 
1706441-35-1
Molecular Formula: 
C12H16N2O
Molecular Weight: 
204.27
2-Cyclohexylisonicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$300.00InquiryInquiry
1g97%$902.00InquiryInquiry
5g97%$4420.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Cyclohexylisonicotinamide
IUPAC Name2-cyclohexylisonicotinamide
Molecular FormulaC12H16N2O
Molecular Weight204.27
SMILESO=C(N)C1=CC=NC(C2CCCCC2)=C1
InChI KeyUKCDTMVVTNKFTN-UHFFFAOYSA-N
Synonym2-Cyclohexyl-isonicotinamide;4-Pyridinecarboxamide, 2-cyclohexyl-
CAS No.1706441-35-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPXBT690 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPXBT690 route product structure diagram
    ACPXBT6901706441-35-1
Inquiry

2. ACPXBT690 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACPXBT690 route product structure diagram
    ACPXBT6901706441-35-1
Inquiry

3. ACPXBT690 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQXGV839 route compound structure diagram
    ACQXGV83929840-73-1In Stock
  2. Plus
  3. ACWVHJ567 route compound structure diagram
    ACWVHJ5674441-56-9In Stock
  4. Then
  5. ACPXBT690 route product structure diagram
    ACPXBT6901706441-35-1
Inquiry

Comments (0)